SCHEMBL26857749

SCHEMBL26857749

N#Cc1ccc2c(c1)/C(=N\O)c1nc3c(Nc4ccc(F)cc4)cccc3c(=O)n1-2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP2 O95551 2/20 0.36
▸ IDO1 P14902 4/20 0.36
▸ TDO2 P48775 3/20 0.36
▸ IDO2 Q6ZQW0 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ APAF1 O14727 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ MITF O75030 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ CDC7 O00311 1/20 0.36
▸ TBXA2R P21731 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26864086 1.00 TDP2 (0.36) TDP2IDO1TDO2IDO2MEN1
SCHEMBL26614267 0.90 IDO1 (0.44) IDO1TDO2IDO2MEN1KMT2A
SCHEMBL26614215 0.89 IDO1 (0.42) TDP2IDO1TDO2IDO2MEN1
SCHEMBL30639114 0.89 IDO1 (0.42) TDP2IDO1TDO2IDO2MEN1
SCHEMBL30639067 0.88 IDO1 (0.47) IDO1TDO2IDO2MEN1KMT2A
SCHEMBL26614101 0.88 IDO1 (0.47) IDO1TDO2IDO2MEN1KMT2A
SCHEMBL26614116 0.79 IDO1 (0.48) IDO1TDO2IDO2MEN1KMT2A
SCHEMBL26855338 0.78 IDO1 (0.47) TDP2IDO1TDO2IDO2MEN1
SCHEMBL26614249 0.77 IDO1 (0.60) IDO1TDO2IDO2MEN1KMT2A
SCHEMBL26614138 0.74 IDO1 (0.55) IDO1TDO2IDO2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023211977-A1 TRYPTANTHRIN DERIVATIVES AND USES THEREOF VISCIENT BIO, INC. (US) 2023-11-02 — — WO disclosed
Send feedback